Singapore · Delayed Price · Currency is SGD Verve Therapeutics Statistics
Total Valuation
SGX:Z74 has a market cap or net worth of SGD 66.22 billion. The enterprise value is 75.18 billion.
| Market Cap | 66.22B |
| Enterprise Value | 75.18B |
Important Dates
The next estimated earnings date is Tuesday, August 19, 2025.
| Earnings Date | Aug 19, 2025 |
| Ex-Dividend Date | Jul 31, 2025 |
Share Statistics
SGX:Z74 has 16.51 billion shares outstanding. The number of shares has increased by 0.01% in one year.
| Current Share Class | 16.51B |
| Shares Outstanding | 16.51B |
| Shares Change (YoY) | +0.01% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 0.03% |
| Owned by Institutions (%) | 22.02% |
| Float | 8.02B |
Valuation Ratios
The trailing PE ratio is 16.76 and the forward PE ratio is 23.90. SGX:Z74's PEG ratio is 1.68.
| PE Ratio | 16.76 |
| Forward PE | 23.90 |
| PS Ratio | 4.68 |
| PB Ratio | 2.55 |
| P/TBV Ratio | 4.06 |
| P/FCF Ratio | 30.62 |
| P/OCF Ratio | 14.37 |
| PEG Ratio | 1.68 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 11.83, with an EV/FCF ratio of 34.77.
| EV / Earnings | 18.71 |
| EV / Sales | 5.31 |
| EV / EBITDA | 11.83 |
| EV / EBIT | 19.07 |
| EV / FCF | 34.77 |
Financial Position
The company has a current ratio of 0.98, with a Debt / Equity ratio of 0.45.
| Current Ratio | 0.98 |
| Quick Ratio | 0.86 |
| Debt / Equity | 0.45 |
| Debt / EBITDA | 3.08 |
| Debt / FCF | 5.40 |
| Interest Coverage | 3.21 |
Financial Efficiency
Return on equity (ROE) is 15.82% and return on invested capital (ROIC) is 2.30%.
| Return on Equity (ROE) | 15.82% |
| Return on Assets (ROA) | 1.85% |
| Return on Invested Capital (ROIC) | 2.30% |
| Return on Capital Employed (ROCE) | 3.58% |
| Revenue Per Employee | 673,624 |
| Profits Per Employee | 191,305 |
| Employee Count | 21,000 |
| Asset Turnover | 0.30 |
| Inventory Turnover | 35.55 |
Taxes
In the past 12 months, SGX:Z74 has paid 564.90 million in taxes.
| Income Tax | 564.90M |
| Effective Tax Rate | 12.30% |
Stock Price Statistics
The stock price has increased by +37.24% in the last 52 weeks. The beta is 0.42, so SGX:Z74's price volatility has been lower than the market average.
| Beta (5Y) | 0.42 |
| 52-Week Price Change | +37.24% |
| 50-Day Moving Average | 3.96 |
| 200-Day Moving Average | 3.50 |
| Relative Strength Index (RSI) | 48.81 |
| Average Volume (20 Days) | 17,795,476 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SGX:Z74 had revenue of SGD 14.15 billion and earned 4.02 billion in profits. Earnings per share was 0.24.
| Revenue | 14.15B |
| Gross Profit | 3.57B |
| Operating Income | 1.37B |
| Pretax Income | 4.59B |
| Net Income | 4.02B |
| EBITDA | 3.37B |
| EBIT | 1.37B |
| Earnings Per Share (EPS) | 0.24 |
Balance Sheet
The company has 2.77 billion in cash and 11.67 billion in debt, giving a net cash position of -8.90 billion or -0.54 per share.
| Cash & Cash Equivalents | 2.77B |
| Total Debt | 11.67B |
| Net Cash | -8.90B |
| Net Cash Per Share | -0.54 |
| Equity (Book Value) | 25.96B |
| Book Value Per Share | 1.51 |
| Working Capital | -187.70M |
Cash Flow
In the last 12 months, operating cash flow was 4.61 billion and capital expenditures -2.45 billion, giving a free cash flow of 2.16 billion.
| Operating Cash Flow | 4.61B |
| Capital Expenditures | -2.45B |
| Free Cash Flow | 2.16B |
| FCF Per Share | 0.13 |
Margins
Gross margin is 25.22%, with operating and profit margins of 9.71% and 28.40%.
| Gross Margin | 25.22% |
| Operating Margin | 9.71% |
| Pretax Margin | 32.47% |
| Profit Margin | 28.40% |
| EBITDA Margin | 23.82% |
| EBIT Margin | 9.71% |
| FCF Margin | 15.28% |
Dividends & Yields
This stock pays an annual dividend of 0.17, which amounts to a dividend yield of 4.24%.
| Dividend Per Share | 0.17 |
| Dividend Yield | 4.24% |
| Dividend Growth (YoY) | 44.27% |
| Years of Dividend Growth | 3 |
| Payout Ratio | 69.88% |
| Buyback Yield | -0.01% |
| Shareholder Yield | 4.23% |
| Earnings Yield | 6.07% |
| FCF Yield | 3.27% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SGX:Z74 has an Altman Z-Score of 2.56 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.56 |
| Piotroski F-Score | 6 |